Company / Free Cash Flow per Share
Astria Therapeutics, Inc. Free Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.45
FY2024
5-year range
-$10.63 / -$1.45
FY2020-FY2024
Trend
+36.1%
vs FY2023
Sector context
#122 of 192
Health Care
What the data says
At $-1.45, Astria Therapeutics, Inc.'s free cash flow per share ranks #122 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-10.63 in FY2020 to $-1.45 in FY2024.
Based on SEC 10-K filings.
-1.45 in FY2024.
Improved from $-2.98 to $-1.45 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 192 in Health CareTop 64% of 192This company -$1.45 Sector average -$19.84
▼
+92.7% above sector average
Key checks
Key Insights
- Astria Therapeutics, Inc.'s free cash flow per share has grown for 4 consecutive years.
- In FY2024, free cash flow per share increased 36.1% year-over-year.
- Ranks #122 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.45 | +36.1% |
| FY2023 | -$2.27 | +23.8% |
| FY2022 | -$2.98 | +11.7% |
| FY2021 | -$3.38 | +68.2% |
| FY2020 | -$10.63 | -287.4% |
| FY2019 | -$2.74 | - |
| FY2018 | - | - |
| FY2017 | -$12.40 | -504.2% |
| FY2016 | -$2.05 | +45.4% |
| FY2015 | -$3.76 | +92.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026